Decker Mark Okey Jr's Form 4 filing
Chiron Real Estate Inc. (XRN) · filed Jun 25, 2025
- Accession no.
- 0001104659-25-062678
- Filed
- Jun 25, 2025
- Trade date
- Jun 23-25, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market purchases total $1.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Decker Mark Okey JrCIK 0001681625 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | Common Stock | PPurchaseAcquired | +100,000 | $6.53F1 | +$653,000 | 100,000 | Direct | |
| Jun 24, 2025 | Common Stock | PPurchaseAcquired | +2,668 | $6.37F2 | +$16,995.16 | 102,668 | Direct | |
| Jun 25, 2025 | Common Stock | PPurchaseAcquired | +30,757 | $6.47F3 | +$198,997.79 | 133,425 | Direct | |
| Jun 25, 2025 | Common Stock | PPurchaseAcquired | +8,072 | $6.56F4 | +$52,952.32 | 141,497 | Direct | |
| Jun 25, 2025 | Common Stock | PPurchaseAcquired | +18,503 | $6.54F5 | +$121,009.62 | 160,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2025 | Common Stock | AGrant or awardAcquired | +158,730 | $0.00 | $0 | 158,730 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.31 to $6.60, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to Global Medical REIT Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (5) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F2
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.32 to $6.40, inclusive. The amount reflected has been rounded to four decimal points.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.44 to $6.505, inclusive. The amount reflected has been rounded to four decimal points.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.555 to $6.585, inclusive. The amount reflected has been rounded to four decimal points.
Referenced by the price of 1 transaction in Table I.
- F5
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.4925 to $6.615, inclusive. The amount reflected has been rounded to four decimal points.
Referenced by the price of 1 transaction in Table I.